Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Waltz

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 24, 2023
Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2Teri Schreiner, Molly Wilson-Murphy, Jan Mendelt-Tillema, et al.
Journal of Child Neurology|September 16, 2025
Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC RegistryMelissa A Wright, Bradley J Barney, Skyler Peterson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 9, 2024
Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosisAmin Ziaei, Olivia Solomon, T Charles Casper, et al.
Multiple Sclerosis and Related Disorders|March 5, 2023
Silent findings: Examination of asymptomatic demyelination in a pediatric US cohortVikram Bhise, Michael Waltz, T Charles Casper, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2022
A new look at cognitive functioning in pediatric MSLauren B Krupp, Emmanuelle Waubant, Michael Waltz, et al.
Pediatric Neurology|June 22, 2023
Demographic Features and Clinical Course of Patients With Pediatric-Onset Multiple Sclerosis on Newer Disease-Modifying TreatmentsNikita Malani Shukla, T Charles Casper, Jayne Ness, et al.
Neurology|September 18, 2025
Cognitive Function in People With Pediatric Multiple Sclerosis Over 2 YearsKimberly A O'Neill, Leigh Charvet, Michael Waltz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 29, 2026
Adenotonsillectomy is associated with increased risk and disease activity in pediatric-onset multiple sclerosisGina Chang, Zahra Nasr, Vinicius Andreoli Schoeps, et al.
Neurology|December 2, 2022
Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum DisorderRaffaella Pizzolato Umeton, Michael Waltz, Gregory S Aaen, et al.
Multiple Sclerosis and Related Disorders|November 4, 2024
Characteristics and predictors of disease course in children initially presenting with ADEMAlice Rutatangwa, Gregory Aaen, Kristen M Krysko, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 24, 2023
Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2Teri Schreiner, Molly Wilson-Murphy, Jan Mendelt-Tillema, et al.
Journal of Child Neurology|September 16, 2025
Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC RegistryMelissa A Wright, Bradley J Barney, Skyler Peterson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 9, 2024
Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosisAmin Ziaei, Olivia Solomon, T Charles Casper, et al.
Multiple Sclerosis and Related Disorders|March 5, 2023
Silent findings: Examination of asymptomatic demyelination in a pediatric US cohortVikram Bhise, Michael Waltz, T Charles Casper, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2022
A new look at cognitive functioning in pediatric MSLauren B Krupp, Emmanuelle Waubant, Michael Waltz, et al.
Pediatric Neurology|June 22, 2023
Demographic Features and Clinical Course of Patients With Pediatric-Onset Multiple Sclerosis on Newer Disease-Modifying TreatmentsNikita Malani Shukla, T Charles Casper, Jayne Ness, et al.
Neurology|September 18, 2025
Cognitive Function in People With Pediatric Multiple Sclerosis Over 2 YearsKimberly A O'Neill, Leigh Charvet, Michael Waltz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 29, 2026
Adenotonsillectomy is associated with increased risk and disease activity in pediatric-onset multiple sclerosisGina Chang, Zahra Nasr, Vinicius Andreoli Schoeps, et al.
Neurology|December 2, 2022
Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum DisorderRaffaella Pizzolato Umeton, Michael Waltz, Gregory S Aaen, et al.
Multiple Sclerosis and Related Disorders|November 4, 2024
Characteristics and predictors of disease course in children initially presenting with ADEMAlice Rutatangwa, Gregory Aaen, Kristen M Krysko, et al.
Pageof 4